| Company: | Cardinal Health |
|---|---|
| CEO: |
|
| Founded: | 1971 |
| Symbol: | CAH |
| Exchange: | NYSE |
| Industry: | Medical - Distribution |
| Sector: | Healthcare |
| About |
Cardinal Health operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele,luding hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offeringslude medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products,ontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio. |
34 among 2804 companies
7000 Cardinal Place
Dublin | OH |
US
| Cardinal Health;CAH;https://bullfincher.io/logos/us/CAH.png;cardinal-health | 222578000000.00 |
|---|---|
| McKesson Corporation;MCK;https://financialmodelingprep.com/image-stock/MCK.png;mckesson-corporation | 403430000000.00 |
| Cencora;COR;https://bullfincher.io/company_logos_external/COR.png;cencora | 321332819000.00 |
Cardinal Health was founded on 1971, which makes the company 55 years old.
Jason Hollar is the CEO of Cardinal Health.
Cardinal Health operates in the Medical - Distribution industry and the Healthcare sector.
Cardinal Health has 57,700 employees.
In fiscal year 2025, Cardinal Health generated a revenue of $222.58 Billion.
In fiscal year 2025, Cardinal Health reported a net income of $1.56 Billion.
Pharmaceutical Member is Cardinal Health's biggest product segment, representing 91.91% of its total revenue.
Cardinal Health went public on Aug 4, 1983, through its Initial Public Offering (IPO), and it has been 42 years since then.
Cardinal Health's ticker symbol is CAH, and the company is listed on the NYSE stock market exchange.
Cardinal Health's current stock price is $223.80 as of Jun 13, 2026.
Ranked #34among 2,804 companies based on market cap.
Competitors of Cardinal Health include McKesson Corporation and Cencora, and more.